Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

NCT00594945 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2014-07-01

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.

Conditions

Interventions

DRUG

Clonazepam

1 Dose

Sponsors & Collaborators

Principal Investigators

  • Beverly Benson, PhD · Jazz Pharmaceuticals

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-12-31
Completion
2009-06-30

Countries

  • United States
  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00594945 on ClinicalTrials.gov